Introduction Degenerative cervical myelopathy (DCM) is the most common cause of non-traumatic
incomplete spinal cord injury, but its pathophysiology is poorly understood. As spinal …

Fingolimod (FTY720, Gilenya, Novartis Pharma AG, Basel, Switzerland) is a sphingosin-1-phosphate
(S1P) receptor modulator with immunomodulatory properties that traps naive and …

Background and Purpose The timing of decision‐making for a surgical intervention in patients
with mild degenerative cervical myelopathy (DCM) is challenging. Spinal cord motion …

7. Esposito S, Gasparini C, Martelli A, Zenga A, Tremolati E, Varin E, et al. Safe administration
of an inactivated virosomal adjuvanted influenza vaccine in asthmatic children with egg …

Multiple sclerosis (MS) is a typical CD4 T cell-mediated autoimmune disease of the central
nervous system (CNS) that leads to inflammation, demyelination, axonal damage, glial …

This study aims to determine tissue-specific neurodegeneration across the spinal cord in
patients with mild-moderate degenerative cervical myelopathy (DCM). Twenty-four mild-…

Objectives Traumatic and non-traumatic spinal cord injury produce neurodegeneration across
the entire neuraxis. However, the spatiotemporal dynamics of spinal cord grey and white …

Introduction Neurogenic lower urinary tract dysfunction (NLUTD), including neurogenic
detrusor overactivity (NDO) and detrusor sphincter dyssynergia, is one of the most frequent and …

Spinal canal narrowing with consecutive spinal cord compression is considered a key
mechanism in degenerative cervical myelopathy (DCM). DCM is a common spine condition …

Opinion statement Despite the development of several injectable or oral treatments for
relapsing-remitting multiple sclerosis (RRMS), it remains difficult to treat patients with aggressive …